Separating favorable from unfavorable prognostic markers in breast cancer: The role of E-cadherin

Cancer Research

Volumn 60, Issue 2, 2000, Pages 298-304

  Heimann, Ruth ^a,b   Lan, Fusheng ^a   McBride, Russell ^a   Hellman, Samuel ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RISK; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DATABASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034650772     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet. 352: 930-942, 1998.
2. Rosen, P. R., Groshen, S., Saigo, P. E., Kinne, D. W., and Hellman, S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J. Clin. Oncol., 7: 355-366, 1989.
3. Quiet, C. A., Ferguson, D. J., Weichselbaum, R. R., and Hellman, S. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow up. J. Clin. Oncol., 13: 1144-1151, 1995.
4. Killion, J. J., and Fidler, I. J. The biology of tumor metastasis. Semin. Oncol., 16: 105-115, 1989.
5. Kohn, E. C., and Liotta, L. A. Invasion and metastasis: new approaches to an old problem. Oncology, 7: 47-62, 1993.
6. Stracke, M. L., and Liotta, L. A. Molecular mechanism of tumor cell metastasis. In: J Mendelsohn, P. Howley, A. Israel, and L. A. Liotta (eds.). The Molecular Basis of Cancer, pp. 233-247. Philadelphia: W. B. Saunders Company, 1995.
7. Folkman, J., and Klagsburn, M. Angiogenic factors. Science (Washington DC). 235: 442-443, 1987.
8. Folkman, J. Clinical application of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
9. Folkman, J. Tumor angiogenesis. In: J. Mendelsohn, P. Howley, A. Israel, and L. A. Liotta (eds.). The Molecular Basis of Cancer, pp. 206-224. Philadelphia: W. B. Saunders Company, 1995.
10. Liotta, L. A., Kleinerman, J., and Saidel, G. M. Quantitative relationship of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor transplantation. Cancer Res., 34: 997-1004, 1974.
11. Liotta, L. A., Kleinerman, J., and Saidel, G. M. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res., 889-894, 1976.
12. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875-1887, 1992.
13. Gasparini, G., Weidner, N., Bevilacqua, P., Maluta, S., Dalla Palma, P., Caffo, O., Barbareschi, M., Boracchi, P., Marubini, E., and Pozza, F. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J. Clin. Oncol., 12: 454-466, 1994.
14. Heimann, R., Ferguson, D., Powers, C., Recant, W. M., Weichselbaum, R. R., and Hellman, S. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J. Natl. Cancer Inst., 88: 1764-1769, 1996.
15. Heimann, R., Ferguson, D., Gray, S., and Hellman, S. Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis. Breast Cancer Res. Treat., 52: 147-158, 1998.
16. Leone, A., Flatow, U., VanHoutte, K., and Steeg, P. Transfection of human nm23H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene, 8: 2325-2333, 1993.
17. Steeg, P. S., De La Rosa, A., Flatow, U., MacDonald, N. J., Benedict, M., and Leone, A. Nm23 and breast cancer metastasis. Breast Cancer Res. Treat., 25: 175-187, 1993.
18. Kantor, J. D., McCormick, B., Steeg, P. S., and Zetter, B. R. Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res., 53: 1971-1973, 1993.
19. Tokunaga, Y., Urano, T., Furukawa, K., Kondo, H., Kanematsu, T., and Shiku, H. Reduced expression of nm23-H1, but not of nm23-H2 is concordant with the frequency of lymph-node metastasis of human breast cancer. Int. J. Cancer. 55: 66-71, 1993.
20. Bevilacqua, G., Sobel, M. E., Liotta, L. A., and Steeg, P. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res., 49: 5185-5190, 1989.
21. Hennessy, C., Henry, J. A., May, F. E. B., Westley, B. R., Angus, B., and Lennard, T. W. J. Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J. Natl. Cancer Inst., 83: 281-285, 1991.
22. Okubo, T., Inokuma, S., Takeda, S., Itoyama, S., Kinoshita, K., and Sugawara, I. Expression of nm23-H1 gene product in thyroid, ovary, and breast cancer. Cell Biophys., 26; 205-213, 1995.
23. Duenas-Gonzales, A.. Abad-Hernanadez, M. M., Garcia-Mata, J., Paz-Bouza, J. I., Cruz-Hernandez, J. J., and Gonzales-Sarmiento, R. Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings. Cancer Lett., 101: 137-142, 1996.
24. Royds, J. A., Stephenson, T. J., Rees, R. C., Shorthouse, A. J., and Silcocks, P. B. Nm23 protein expression in ductal carcinoma in situ and invasive human breast carcinoma. J. Natl. Cancer Inst., 85: 727-731, 1993.
25. Barnes, R., Massood, S., Barker, E., Rosengard, A. M., Coggin, D. L., Crowell, T., King, C. R., Porter-Jordan, K., Wargortz, E. S., Liotta, L. A., and Steeg, P. S. Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am. J. Pathol., 139: 245-250, 1991.
26. Toulas, C., Mihura, J., de Balincourt, C., Marques, B., Marek, E., Soula, G., Roche, H., and Favre, G. Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody. Br. J. Cancer, 73: 630-635, 1996.
27. Heimann, R., Ferguson, D., and Hellman, S. The relationship of nm23 and angiogenesis to the metastatic propensity of node-negative breast cancer. Cancer Res., 58: 2766-2711, 1998.
28. Berx, G., Staes, K., van Hengel, J., Molemans, F., Bussemakers, M. J., van Bokhoven, A., and van Roy, F. Cloning and characterization of the human invasion suppressor gene E- cadherin (CDH1). Genomics, 26: 281-289, 1995.
29. Bracke, M. E., van Roy, F. M., and Mareel, M. M. The E-cadherin/catenin complex in invasion and metastasis. Curr. Top. Microbiol. Immunol., 213: 123-161, 1996.
30. Jensen, P. J., and Wheelock, M. J. Regulation of urokinase plasminogen activator localization in keratinocytes by calcium ion and E-cadherin. Exp. Cell Res., 202: 190-198, 1992.
31. Suarez-Quian, C. A., and Byers. S. W. Redistribution of epidermal growth factor receptor as a function of cell density, cell-cell adhesion and calcium in human (A-431) cells. Tissue Cell, 25: 1-17, 1993.
32. Takeichi, M. Cadherin cell adhesion receptors as a morphogenic regulator. Science (Washington DC), 251: 1451-1455, 1991.
33. Takeichi, M. Morphogenic roles of classic cadherins. Curr. Opin. Cell Biol., 7: 619-627, 1995.
34. Larue, L., Ohsugi, M., Hirchenhain, J., and Kemler, R. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc. Natl. Acad. Sci. USA. 91: 8263-8267, 1994.
35. Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D., and Birchmeier, W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 113: 173-185, 1991.
36. Vleminckx, K., Vakaet, L., Jr., Mareel, M., Fiers, W., and van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66: 107-119, 1991.
37. Meiners, S., Brinkmann, V., Naundorf, H., and Birchmeier, W. Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene, 16: 9-20, 1998.
38. Takeichi, M. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol., 5: 806-811, 1993.
39. Oka, H., Shiozaki, H., Kobayashi, K., Inoue, M., Tahara, H., Kobayashi, T., Takatsuka, Y., Matsuyoshi, N., Hirano, S., Takeichi, M., and Mori, T. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res., 53: 1696-1701, 1993.
40. Siitonen, S. M., Kononen, J. T., Helin, H. J., Rantala, I. S., Holli, K. A., and Isola, J. J. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am. J. Clin. Pathol., 105: 394-402, 1996.
41. Hunt, N. C., Douglas-Jones, A. G., Jasani, B., Morgan, J. M., and Pignatelli, M. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch., 430: 285-289, 1997.
42. Guriec, N., Marcellin, L., Gairard, B., Calderoli, H., Wilk, A., Renaud, R., Bergerat, J. P., and Oberling, F. E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival. Invasion Metastasis. 16: 19-26, 1996.
43. Charpin, C., Garcia, S., Bonnier, P., Martini, F., Andrac, L., Choux, R., Lavaut, M. N., and Allasia, C. Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival. Am. J. Clin. Pathol., 109: 431-438, 1998.
44. Lipponen, P., Saarelainen, E., Ji, H., Aaltomaa, S., and Syrjanen, K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J. Pathol., 174: 101-109, 1994.
45. Ferguson, D. J., Meier, P., Karrison, T., Dawson, P. J., Straus, F. H., and Lowenstein, F. E. Staging of breast cancer and survival rates. An assessment based on 50 years of experience with radical mastectomy. JAMA, 248: 1337-1341, 1982.
46. Quiet, C. A., Ferguson, D. J., Weichselbaum, R. R., and Hellman, S. Natural history of node-positive breast cancer: the curability of small cancers with limited number of positive nodes. J. Clin. Oncol., 14: 3105-3111, 1996.
47. Heimann, R., Ferguson, D., Powers, C., Suri, D., Weichselbaum, R. R., and Hellman, S. Race and clinical outcome in breast cancer in a series with long follow-up evaluation. J. Clin. Oncol., 15: 2329-2337, 1997.
48. Heimann, R., and Hellman, S. Aging, progression, and phenotype in breast cancer. J. Clin. Oncol., 16: 2686-2692, 1998.
49. Karrison, T. G., Ferguson, D. J., and Meier, P. Dormancy of mammary carcinoma after mastectomy. J. Natl. Cancer Inst., 91: 80-85, 1999.
50. Heimann, R., and Hellman, S. Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J. Clin. Oncol., in press, 2000.
51. Fisher, E. R., Redmond, C., and Fisher, B. Histologic grading of breast cancer. Pathol. Annu., 15: 239-251, 1980.
52. Miller, R. T. Immunohistochemistry in the community practice of pathology. Lab. Med., 22: 527-532, 1991.
53. Shimoyama, Y., Hirohashi, S., Hirano, S., Noguchi, M., Shimosato, Y., Takeichi, M.. and Abe, O. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res., 49: 2128-2133, 1989.
54. von Wasielewski, R., Rhein, A., Werner, M., Scheumann, G. F., Dralle, H., Potter, E., Brabant, G., and Georgii, A. Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. Cancer Res., 57; 2501-2507, 1997.
55. Weidner, N. P. S. J., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
56. Gasparini, G., and Harris, A. L. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J. Clin. Oncol., 13: 765-782, 1995.
57. Weidner, N., and Folkman, J. Tumor vascularity as a prognostic factor in cancer. PPO Updates, 11; 1-24, 1997.
58. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
59. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.